Exactly what I’m thinking, shouldn’t the study design already been discussed with and approved by FDA before they roll it out in the first place? What’s the point of running a marathon only to find out at the finish line that we weren’t qualify to participate in the first place?
MSB to dispute FDA finding in Type A meeting, page-495
-
- There are more pages in this discussion • 523 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.013(1.07%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.15 | $787.4K | 677.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 27029 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 42895 | 7 |
View Market Depth
| Last trade - 10.38am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |